| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |